David R. Matthews

98.3k total citations · 20 hit papers
272 papers, 75.4k citations indexed

About

David R. Matthews is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, David R. Matthews has authored 272 papers receiving a total of 75.4k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Endocrinology, Diabetes and Metabolism, 76 papers in Surgery and 76 papers in Molecular Biology. Recurrent topics in David R. Matthews's work include Diabetes Treatment and Management (105 papers), Diabetes Management and Research (97 papers) and Metabolism, Diabetes, and Cancer (69 papers). David R. Matthews is often cited by papers focused on Diabetes Treatment and Management (105 papers), Diabetes Management and Research (97 papers) and Metabolism, Diabetes, and Cancer (69 papers). David R. Matthews collaborates with scholars based in United Kingdom, United States and Australia. David R. Matthews's co-authors include R. C. Turner, A. Rudenski, B A Naylor, J P Hosker, DF Treacher, Rury R. Holman, T. M. Wallace, J Lévy, H. A. W. Neil and M. Angelyn Bethel and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

David R. Matthews

265 papers receiving 72.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1985 27.1k citations David R. Matthews, R. C. Turner et al. Diabetologia profile →
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

2008 5.5k citations Rury R. Holman, David R. Matthews et al. profile →
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

2017 5.4k citations Bruce Neal, Vlado Perkovic et al. profile →
Use and Abuse of HOMA Modeling

2004 4.1k citations J Lévy, David R. Matthews et al. Diabetes Care profile →
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2012 3.2k citations Απόστολος Τσάπας, David R. Matthews et al. Diabetologia profile →
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

2012 2.6k citations Απόστολος Τσάπας, David R. Matthews et al. Diabetes Care profile →
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2014 2.4k citations Απόστολος Τσάπας, David R. Matthews et al. Diabetes Care profile →
Publication bias in clinical research

1991 2.4k citations David R. Matthews et al. profile →
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)

1998 1.5k citations Irene Stratton, David R. Matthews et al. profile →
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

2008 939 citations David R. Matthews et al. Diabetes Care profile →
Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study

2005 693 citations David R. Matthews et al. Diabetic Medicine profile →
Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

2013 690 citations Thomas Karagiannis, Maria Mainou et al. profile →
Resistance to Insulin Therapy Among Patients and Providers

2005 627 citations David R. Matthews et al. Diabetes Care profile →
The assessment of insulin resistance in man

2002 541 citations David R. Matthews et al. Diabetic Medicine profile →
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2015 528 citations Απόστολος Τσάπας, David R. Matthews et al. Diabetologia profile →
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes

2008 504 citations Rury R. Holman, David R. Matthews et al. profile →
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

2018 468 citations Vlado Perkovic, Dick de Zeeuw et al. profile →
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events

2017 375 citations Kenneth W. Mahaffey, Bruce Neal et al. Circulation profile →
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

2018 368 citations Vlado Perkovic, Kenneth W. Mahaffey et al. Circulation profile →
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis

2022 176 citations Thomas Karagiannis, Ioannis Avgerinos et al. Diabetologia profile →

Peers

Countries citing papers authored by David R. Matthews

Since Specialization

Citations

This map shows the geographic impact of David R. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Matthews more than expected).

Fields of papers citing papers by David R. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Matthews. The network helps show where David R. Matthews may publish in the future.

Co-authorship network of co-authors of David R. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Matthews. A scholar is included among the top collaborators of David R. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Matthews. David R. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjusting the Use of Glucose-Lowering Agents in the Real-World Clinical Management of People with Type 2 Diabetes: A Narrative Review 2023 ·Diabetes Therapy ·Siew Pheng Chan, Lee‐Ling Lim, Juliana C.N. Chan, David R. Matthews	5
2	Ultra‐rapid‐acting insulins for adults with diabetes: A systematic review and meta‐analysis 2021 ·Diabetes Obesity and Metabolism ·Ioannis Avgerinos, (unknown), Thomas Karagiannis, (unknown), Aris Liakos, Maria Mainou, David R. Matthews, Απόστολος Τσάπας, Eleni Bekiari	22
3	Sotagliflozin for patients with type 2 diabetes: A systematic review and meta‐analysis 2021 ·Diabetes Obesity and Metabolism ·Ioannis Avgerinos, Thomas Karagiannis, (unknown), (unknown), Aris Liakos, David R. Matthews, Απόστολος Τσάπας, Eleni Bekiari	27
4	How might technology rise to the challenge of data sharing in agri-food? 2021 ·Global Food Security ·(unknown), Milan Marković, David R. Matthews, (unknown), Georgios Leontidis, Jessica Enright	53
5	Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature 2020 ·Diabetologia ·Prasad Katulanda, Harsha Dissanayake, (unknown), (unknown), (unknown), (unknown), Kavinga Kalhari Kobawaka Gamage, Nipun Lakshitha de Silva, Manilka Sumanatilleke, Noel Somasundaram, David R. Matthews	115
6	Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis 2020 ·Diabetes Obesity and Metabolism ·Ioannis Avgerinos, Apostolos Manolopoulos, (unknown), Konstantinos Kitsios, Aris Liakos, Thomas Karagiannis, (unknown), David R. Matthews, Απόστολος Τσάπας, Eleni Bekiari	29
7	Oral semaglutide for type 2 diabetes: A systematic review and meta‐analysis 2019 ·Diabetes Obesity and Metabolism ·Ioannis Avgerinos, (unknown), Aris Liakos, Thomas Karagiannis, David R. Matthews, Απόστολος Τσάπας, Eleni Bekiari	56
8	Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program 2019 ·Diabetologia ·Zien Zhou, Meg Jardine, Vlado Perkovic, David R. Matthews, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Mehul Desai, Richard Oh, Robin Simpson, Nelson B. Watts, Bruce Neal	59
9	Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program 2019 ·Journal of the American Society of Nephrology ·Brendon L. Neuen, Toshiaki Ohkuma, Bruce Neal, David R. Matthews, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Qiang Li, Meg Jardine, Richard Oh, Hiddo J.L. Heerspink, Vlado Perkovic	101
10	The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme 2019 ·Diabetologia ·K. W. Mahaffey, Jiapeng Li, Sunil V. Badve, Zhong‐Bo Zhou, Richard Oh, (unknown), Vlado Perkovic, Dick de Zeeuw, (unknown), David R. Matthews, Bruce Neal	1
11	Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events breakdown → 2017 ·Circulation ·Kenneth W. Mahaffey, Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Elisa Fabbrini, Tao Sun, Qiang Li, Mehul Desai, David R. Matthews	375
12	The prevalence, predictors and associations of hypertension in Sri Lanka: A cross-sectional population based national survey 2014 ·Faculty of Health; Institute of Health and Biomedical Innovation ·Prasad Katulanda, Priyanga Ranasinghe, Ranil Jayawardena, Godwin Constantine, Rezvi Sheriff, David R. Matthews	4
13	Expansion of the Homeostasis Model Assessment of β-Cell Function and Insulin Resistance to Enable Clinical Trial Outcome Modeling Through the Interactive Adjustment of Physiology and Treatment Effects: iHOMA2 2013 ·Diabetes Care ·Nathan R. Hill, J Lévy, David R. Matthews	88
14	Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes 2005 ·Diabetes Research and Clinical Practice ·G Belcher, (unknown), (unknown), Richard Urquhart, David R. Matthews	71
15	Mid-Follicular Phase Pulses of Inhibin B Are Absent in Polycystic Ovarian Syndrome and Are Initiated by Successful Laparoscopic Ovarian Diathermy: A Possible Mechanism Regulating Emergence of the Dominant Follicle 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Gillian Lockwood, Shanthi Muttukrishna, Nigel P. Groome, David R. Matthews, William J. Ledger	96
16	UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years 1998 ·Diabetic Medicine ·(unknown), David R. Matthews, C A Cull, Irene Stratton, Rury R. Holman, R. C. Turner	346
17	The OK Health Check: A Health Assessment Checklist for People with Learning Disabilities 1997 ·British Journal of Learning Disabilities ·David R. Matthews, John Hegarty	24
18	UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM 1995 ·Diabetologia ·Bernard Keavney, Christopher Dudley, Irene Stratton, R R Holman, David R. Matthews, Peter J. Ratcliffe, R. C. Turner	4
19	A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24‐hour growth hormone profiles 1991 ·Clinical Endocrinology ·David R. Matthews, Peter C. Hindmarsh, P J Pringle, C G Brook	32
20	Patient evaluation of a pen‐sized glucose meter 1988 ·Practical Diabetes International ·(unknown), (unknown), David R. Matthews	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact